ibuprofen has been researched along with 2019 Novel Coronavirus Disease in 33 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
| Excerpt | Relevance | Reference |
|---|---|---|
| "Insured patients with a history of osteoarthritis or back pain and receiving ibuprofen, other ns-NSAIDs, COX-2i or paracetamol between 1 November, 2019 and 31 January, 2020 (study enrolment window 1) or between 1 February, 2020 and 31 October, 2020 (study enrolment window 2)." | 9.41 | Risk of COVID-19 Diagnosis and Hospitalisation in Patients with Osteoarthritis or Back Pain Treated with Ibuprofen Compared to Other NSAIDs or Paracetamol: A Network Cohort Study. ( Argyriou, G; Brash, JT; Driessen, S; Prieto-Alhambra, D; Reich, C; Seager, S; Turkmen, C; Varrassi, G; Xie, J, 2023) |
| "Insured patients with a history of osteoarthritis or back pain and receiving ibuprofen, other ns-NSAIDs, COX-2i or paracetamol between 1 November, 2019 and 31 January, 2020 (study enrolment window 1) or between 1 February, 2020 and 31 October, 2020 (study enrolment window 2)." | 5.41 | Risk of COVID-19 Diagnosis and Hospitalisation in Patients with Osteoarthritis or Back Pain Treated with Ibuprofen Compared to Other NSAIDs or Paracetamol: A Network Cohort Study. ( Argyriou, G; Brash, JT; Driessen, S; Prieto-Alhambra, D; Reich, C; Seager, S; Turkmen, C; Varrassi, G; Xie, J, 2023) |
| " One hundred and seventy-nine (44%) patients had fever, with 32% using paracetamol and 22% using ibuprofen, for symptom-relief." | 3.96 | Ibuprofen use and clinical outcomes in COVID-19 patients. ( Bar-Haim, A; Kozer, E; Rinott, E; Shapira, Y; Youngster, I, 2020) |
| " Globally, the pharmacologic treatment of pain in pediatric patients is limited largely to nonopioid analgesics, and dosing must account for differences in age, weight, metabolism, and risk of adverse effects." | 3.01 | Common Selfcare Indications of Pain Medications in Children. ( Bell, J; Kachroo, P; Mossali, VM; Siddiqui, K; Zempsky, W, 2023) |
| "At the start of the coronavirus disease 2019 (COVID-19) pandemic (March 2020), there was speculation that non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, used to manage some of the symptoms of COVID-19, could increase the susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and negatively impact clinical outcomes." | 3.01 | Ibuprofen, other NSAIDs and COVID-19: a narrative review. ( Charlesworth, B; Laughey, W; Lodhi, I; Pennick, G; Sandhu, S; Sanni, O; Smart, L, 2023) |
| "non-ibuprofen patients were 16." | 1.56 | Association Between Prescribed Ibuprofen and Severe COVID-19 Infection: A Nationwide Register-Based Cohort Study. ( Andersen, MP; Bang, CN; Butt, JH; Fosbøl, E; Gerds, TA; Gislason, G; Kragholm, K; Køber, L; Pallisgaard, J; Phelps, M; Schou, M; Torp-Pedersen, C; Østergaard, L, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 33 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wong, J | 1 |
| Sharma, S | 1 |
| Yao, JV | 1 |
| Aggarwal, A | 1 |
| Grigg, L | 1 |
| de Bruin, N | 1 |
| Schneider, AK | 1 |
| Reus, P | 1 |
| Talmon, S | 1 |
| Ciesek, S | 1 |
| Bojkova, D | 1 |
| Cinatl, J | 1 |
| Lodhi, I | 2 |
| Charlesworth, B | 3 |
| Sinclair, S | 1 |
| Pennick, G | 3 |
| Laughey, WF | 1 |
| Gribbon, P | 1 |
| Kannt, A | 1 |
| Schiffmann, S | 1 |
| Schneider, T | 1 |
| Mauermann, E | 1 |
| Ilgenstein, B | 1 |
| Jaquiery, C | 1 |
| Ruppen, W | 1 |
| Abdool-Ghany, AA | 1 |
| Sahwell, PJ | 1 |
| Klaus, J | 1 |
| Gidley, ML | 1 |
| Sinigalliano, CD | 1 |
| Solo-Gabriele, HM | 1 |
| Xie, J | 1 |
| Brash, JT | 1 |
| Turkmen, C | 1 |
| Driessen, S | 1 |
| Varrassi, G | 1 |
| Argyriou, G | 1 |
| Seager, S | 1 |
| Reich, C | 1 |
| Prieto-Alhambra, D | 1 |
| Kasprzyk-Hordern, B | 1 |
| Sims, N | 1 |
| Farkas, K | 1 |
| Jagadeesan, K | 1 |
| Proctor, K | 1 |
| Wade, MJ | 1 |
| Jones, DL | 1 |
| Karami, S | 1 |
| Asonye, C | 1 |
| Pinnow, E | 1 |
| Pratt, V | 1 |
| McCulley, L | 1 |
| Dwumfour, N | 1 |
| Zhou, EH | 1 |
| Zempsky, W | 1 |
| Bell, J | 1 |
| Mossali, VM | 1 |
| Kachroo, P | 1 |
| Siddiqui, K | 1 |
| Marcianò, G | 1 |
| Muraca, L | 1 |
| Rania, V | 1 |
| Gallelli, L | 1 |
| Apata, J | 1 |
| Pennap, DD | 1 |
| Mosholder, AD | 1 |
| Laughey, W | 1 |
| Smart, L | 2 |
| Sanni, O | 1 |
| Sandhu, S | 1 |
| Sodhi, M | 1 |
| Etminan, M | 1 |
| MaassenVanDenBrink, A | 1 |
| de Vries, T | 1 |
| Danser, AHJ | 1 |
| Vanegas Ramirez, A | 1 |
| Efe, D | 1 |
| Fischer, M | 1 |
| Zolk, O | 1 |
| Hafner, S | 1 |
| Schmidt, CQ | 1 |
| Arjomandi Rad, A | 1 |
| Vardanyan, R | 1 |
| Tas, NR | 1 |
| Veljkovic, V | 4 |
| Vergara-Alert, J | 4 |
| Segalés, J | 4 |
| Paessler, S | 4 |
| Cui, S | 1 |
| Chen, S | 1 |
| Ke, L | 1 |
| Dhillon, P | 1 |
| Breuer, M | 1 |
| Hirst, N | 1 |
| Martins-Filho, PR | 1 |
| do Nascimento-Júnior, EM | 1 |
| Santos, VS | 1 |
| Moore, N | 1 |
| Carleton, B | 1 |
| Blin, P | 1 |
| Bosco-Levy, P | 1 |
| Droz, C | 1 |
| Rinott, E | 1 |
| Kozer, E | 1 |
| Shapira, Y | 1 |
| Bar-Haim, A | 1 |
| Youngster, I | 1 |
| Fawkes, N | 1 |
| Goggin, P | 1 |
| Rainsford, KD | 1 |
| Shah, N | 1 |
| Vaja, R | 1 |
| Chan, JSK | 1 |
| Ferreira, P | 1 |
| Harky, A | 1 |
| Rogers, LJ | 1 |
| Gashaw, HH | 1 |
| Kirkby, NS | 1 |
| Mitchell, JA | 1 |
| Vosu, J | 1 |
| Britton, P | 1 |
| Howard-Jones, A | 1 |
| Isaacs, D | 1 |
| Kesson, A | 1 |
| Khatami, A | 1 |
| Marais, B | 1 |
| Nayda, C | 1 |
| Outhred, A | 1 |
| Kelleni, MT | 1 |
| Kragholm, K | 1 |
| Gerds, TA | 1 |
| Fosbøl, E | 1 |
| Andersen, MP | 1 |
| Phelps, M | 1 |
| Butt, JH | 1 |
| Østergaard, L | 1 |
| Bang, CN | 1 |
| Pallisgaard, J | 1 |
| Gislason, G | 1 |
| Schou, M | 1 |
| Køber, L | 1 |
| Torp-Pedersen, C | 1 |
| Quaglietta, L | 1 |
| Martinelli, M | 1 |
| Staiano, A | 1 |
| Toom, S | 1 |
| Wolf, B | 1 |
| Avula, A | 1 |
| Peeke, S | 1 |
| Becker, K | 1 |
| Valenzuela, R | 1 |
| Pedrosa, MA | 1 |
| Garrido-Gil, P | 1 |
| Labandeira, CM | 1 |
| Navarro, G | 1 |
| Franco, R | 1 |
| Rodriguez-Perez, AI | 1 |
| Labandeira-Garcia, JL | 1 |
| Poutoglidou, F | 1 |
| Saitis, A | 1 |
| Kouvelas, D | 1 |
| Salva, O | 1 |
| Alasino, R | 1 |
| Giller, C | 1 |
| Borello, J | 1 |
| Doresky, A | 1 |
| Karayan, G | 1 |
| Beltramo, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Extended Compassionate Use Program (UCA) With Inhalational Ibuprofen in Patients With Acute Respiratory Pathology, Mediated by COVID-19.[NCT04382768] | 40 participants (Anticipated) | Interventional | 2020-05-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for ibuprofen and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Risk of COVID-19 Diagnosis and Hospitalisation in Patients with Osteoarthritis or Back Pain Treated with Ibuprofen Compared to Other NSAIDs or Paracetamol: A Network Cohort Study.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Back Pain; Cohort Studies; COVID-19; COVID-1 | 2023 |
Common Selfcare Indications of Pain Medications in Children.
Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Child; COVID-19; Fever; Humans; Ibuprofen; Pain | 2023 |
Ibuprofen in the Management of Viral Infections: The Lesson of COVID-19 for Its Use in a Clinical Setting.
Topics: Anti-Inflammatory Agents, Non-Steroidal; COVID-19; Humans; Ibuprofen; Inflammation; Pain | 2023 |
Ibuprofen, other NSAIDs and COVID-19: a narrative review.
Topics: Anti-Inflammatory Agents, Non-Steroidal; COVID-19; COVID-19 Vaccines; Humans; Ibuprofen; SARS-CoV-2 | 2023 |
COVID-19 pandemic and therapy with ibuprofen or renin-angiotensin system blockers: no need for interruptions or changes in ongoing chronic treatments.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammato | 2020 |
COVID-19 breakthroughs: separating fact from fiction.
Topics: Adult; Aged; Child; COVID-19; Evidence-Based Medicine; Female; Fomites; Humans; Ibuprofen; Male; Nic | 2020 |
A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality.
Topics: Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents, Non-Steroidal; Coronavirus Infections; CO | 2020 |
The COVID-19 ibuprofen controversy: A systematic review of NSAIDs in adult acute lower respiratory tract infections.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; COVID-19; COVID-19 Drug Treatment; | 2021 |
Serious infectious events and ibuprofen administration in pediatrics: a narrative review in the era of COVID-19 pandemic.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Communicable Diseases; COVID-19; COVID-19 Drug Treat | 2021 |
2 trials available for ibuprofen and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Analgesic benefit of metamizole and ibuprofen vs. either medication alone: a randomized clinical trial.
Topics: Analgesics; COVID-19; Cross-Over Studies; Dipyrone; Double-Blind Method; Humans; Ibuprofen; Pain, Po | 2022 |
Nebulization with alkaline hipertonic ibuprofen induces a rapid increase in platelets circulating in COVID-19 patients but not in healthy subjects.
Topics: Adult; Blood Platelets; COVID-19; COVID-19 Drug Treatment; Enoxaparin; Female; Humans; Ibuprofen; Ma | 2022 |
22 other studies available for ibuprofen and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
COVID-19 mRNA vaccine (Comirnaty)-induced myocarditis.
Topics: Bisoprolol; BNT162 Vaccine; COVID-19; Drug Therapy, Combination; Electrocardiography; Heart; Humans; | 2022 |
Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection.
Topics: Acetaminophen; Angiotensin-Converting Enzyme 2; Animals; Anti-Inflammatory Agents, Non-Steroidal; Ca | 2022 |
Fecal indicator bacteria levels at a marine beach before, during, and after the COVID-19 shutdown period and associations with decomposing seaweed and human presence.
Topics: Acetaminophen; Animals; Bacteria; Bathing Beaches; Caffeine; COVID-19; Dogs; Enterococcus; Environme | 2022 |
Wastewater-based epidemiology for comprehensive community health diagnostics in a national surveillance study: Mining biochemical markers in wastewater.
Topics: Biomarkers; COVID-19; COVID-19 Testing; Humans; Ibuprofen; Public Health; SARS-CoV-2; Wastewater; Wa | 2023 |
Trends in pediatric nonprescription analgesic/antipyretic exposures during the COVID-19 pandemic.
Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Antipyretics; Aspirin; Child; Child, Preschool; | 2023 |
The use of analgesics for intentional self-poisoning: Trends in U.S. poison center data.
Topics: Acetaminophen; Adolescent; Adult; Analgesics; Aspirin; Child; COVID-19; Female; Humans; Ibuprofen; M | 2023 |
EMA advice on the use of NSAIDs for Covid-19.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 | 2020 |
Safety of Ibuprofen in Patients With COVID-19: Causal or Confounded?
Topics: Acetaminophen; Antipyretics; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Ibuprofen; P | 2020 |
Headache medication and the COVID-19 pandemic.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inh | 2020 |
Drug-induced vasculitis in a patient with COVID-19.
Topics: Anti-Bacterial Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Ibuprofen; | 2020 |
Ibuprofen and thromboembolism in SARS-COV2.
Topics: COVID-19; Humans; Ibuprofen; RNA, Viral; SARS-CoV-2; Thromboembolism | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Reply to "Ibuprofen and thromboembolism in SARS-COV2".
Topics: COVID-19; Humans; Ibuprofen; Pandemics; SARS-CoV-2; Thromboembolism | 2020 |
No current evidence supporting risk of using Ibuprofen in patients with COVID-19.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Betacoronavirus; Coronavirus Infections; COVID-19; Diabetes | 2020 |
Does Ibuprofen Worsen COVID-19?
Topics: Acute Disease; Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents, Non-Steroidal; Betacoronav | 2020 |
Ibuprofen use and clinical outcomes in COVID-19 patients.
Topics: Acetaminophen; Adult; Antipyretics; COVID-19; COVID-19 Drug Treatment; Female; Fever; Humans; Ibupro | 2020 |
Is the risk of ibuprofen or other non-steroidal anti-inflammatory drugs increased in COVID-19?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Coronavirus Infections; COVID-19; COVID-19 Drug Trea | 2020 |
ACEIs, ARBs, ibuprofen originally linked to COVID-19: the other side of the mirror.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents | 2020 |
Association Between Prescribed Ibuprofen and Severe COVID-19 Infection: A Nationwide Register-Based Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; COVID-19; Drug Prescriptions; Female; Humans; Ibupro | 2020 |
Familial thrombocytopenia flare-up following the first dose of mRNA-1273 Covid-19 vaccine.
Topics: 2019-nCoV Vaccine mRNA-1273; Adult; Analgesics, Non-Narcotic; Chronic Disease; COVID-19; COVID-19 Va | 2021 |
Interactions between ibuprofen, ACE2, renin-angiotensin system, and spike protein in the lung. Implications for COVID-19.
Topics: Angiotensin-Converting Enzyme 2; Animals; COVID-19; Disease Models, Animal; Humans; Ibuprofen; Lung; | 2021 |
Ibuprofen and COVID-19 disease: separating the myths from facts.
Topics: Anti-Inflammatory Agents, Non-Steroidal; COVID-19; Cytokines; Humans; Ibuprofen; SARS-CoV-2 | 2021 |